ABCA1 and diabetic kidney disease: At the same time, treatment approaches for podocyte injury have also been proposed, including drug intervention (such as drugs that activate ABCA1 expression) and gene therapy (such as gene therapy that increases ABCA1 gene expression), which may become new approaches for treating DKD.